SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
June 1, 2001 (May 31, 2001)
Date of Report (Date of earliest event reported)
------------------
INTERPORE INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-22958 95-3043318
(State or other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
181 Technology Drive 92618
Irvine, California (Zip Code)
(Address of principal executive offices)
(949) 453-3200
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events.
On May 31, 2001, Interpore International, Inc., announced that it has agreed to
acquire American OsteoMedix Corporation. The press release dated May 31, 2001
announcing this transaction is filed as Exhibit 99.1 hereto and incorporated
herein by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
99.1 Press release dated May 31, 2001 relating to a definitive agreement
for the acquisition of American OsteoMedix Corporation by Interpore
International, Inc.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Interpore International, Inc.
Date: June 1, 2001 By: /s/ Richard L. Harrison
______________________________________________
Richard L. Harrison
Sr. Vice President and Chief Financial Officer
3
EXHIBIT INDEX
Exhibit
Number Exhibit Description
- ------- --------------------------------------------------------------------
99.1 Press release dated May 31, 2001 relating to a definitive agreement
for the acquisition of American OsteoMedix Corporation by Interpore
International, Inc.